-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O1.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Outcomes in Pediatric, Adolescent and Young Adult Patients

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, ALL, Lymphoid Leukemias, Clinical Practice (Health Services and Quality), Translational Research, Bone Marrow Failure Syndromes, Clinical Research, Thalassemia, Supportive Care, Pediatric, Hemoglobinopathies, Diversity, Equity, and Inclusion (DEI), Diseases, Immune Disorders, Immunodeficiency, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Room 6DE (San Diego Convention Center)
Moderators:
Hisham Abdel Azim, MD, Loma Linda Cancer Center and Pashna N. Munshi, MD, H. Lee Moffitt Cancer Center
Disclosures:
No relevant conflicts of interest to declare.

This session will focus on strategies to improve transplant outcomes for pediatric-AYA patients through optimization of donor selection, preparative regimens and supportive care.
4:00 PM

Oana Mirci-Danicar, MD, PhD1*, Madeleine Powys, MD2,3*, Maharshi Trivedi, MD4,5*, Giorgio Ottaviano6*, Khushnuma Mullanfiroze, MD7*, Avijeet Mishra, MD7*, Rebecca Palmer, MD4*, Claire Horgan, MD PhD3*, Ramya Hanasoge-Nataraj, MD3*, Wing Roberts, MD8*, Valerie Broderick, MD9*, Pamela Evans, MD PhD9*, Katharine Patrick, MD10*, Mary Slatter, MD11*, Persis Jal Amrolia7*, Beki James, MD12*, Robert Wynn, MD3* and Kanchan Rao, MD7*

1Bristol Royal Hospital for Children, Bone Marrow Transplant Unit, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, ENG, United Kingdom
2The Children's Hospital At Westmead, Westmead, AUS
3Royal Manchester Children's Hospital, Blood and Marrow Transplant Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom
4Bristol Royal Hospital for Children, Bone Marrow Transplant Unit, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
5Department of Pediatric Oncology, Gujarat Cancer and Research Institute, Ahmedabad, India
6Department of Pediatrics, Bone Marrow Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
7Bone Marrow Transplant Department, Great Ormond Street Hospital, London, United Kingdom
8Paediatric Bone Marrow Transplant Unit, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom
9Children’s Health Ireland at Crumlin, Dublin, Ireland
10Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom
11Paediatric Stem Cell Transplant Unit, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom
12Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom

4:15 PM

Fabiana Cacace1,2*, Shaikha Alqahtani, MD2*, Taylor McMichael, MSN, RN, CPNP-AC2*, Carmem Bonfim, MD, PhD2*, Andrea Bauchat, DO2*, Timothy A. Driscoll2*, Paul L. Martin, MD, PhD2, Joanne Kurtzberg, MD2 and Kris Michael Mahadeo, MD2

1Stem Cell Transplantation and Cell Therapy Unit, AORN Santobono Pausilipon, Naples, Italy
2Pediatric Transplantation and Cellular Therapy, Duke University, Durham, NC

4:30 PM

Thomas Pfeiffer1*, Stephanie Hyde1*, Shalini Shenoy, MD1, Melissa Mavers1*, Robert J. Hayashi1*, Feng Gao2*, Lisa Madden3*, Troy Quigg4, Michael J. Eckrich5, Sima Bhatt6 and Jeffrey J. Bednarski, MD, PhD1

1Department of Pediatrics, Division of Hematology / Oncology, Washington University School of Medicine, Saint Louis, MO
2Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO
3Department of Pediatrics, Division of Hematology / Oncology, University of California Davis, Sacramento, CA
4Pediatric Blood & Bone Marrow Transplant and Cellular Therapy, Helen DeVos Children's Hospital, Grand Rapids, MI
5Atrium Health Levine Children's Hospital and Wake Forest School of Medicine, Charlotte, NC
6Disc Medicine, Watertown, MA

4:45 PM

Alexia Gonzalez, MD1*, Ana Laura Varela Constantino, MD2*, Nereida Méndez-Ramírez1*, Fernando J Medina-Olivares1*, Eli Fuentes-Chavez1*, Rosario Salazar-Riojas1*, César Homero Gutierrez-Aguirre, MD1*, Olga Cantu, MD1*, Perla Colunga-Pedraza1*, Luz Tarin-Arzaga, MD1*, Xitlaly Judith Gonzalez Leal, MD2, Elías Eugenio Gonzalez-López, MD3*, David Gomez-Almaguer, MD1,3 and Andres Gomez-De Leon, MD1,3

1Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Monterrey, NL, Mexico
2Tec Salud, Instituto Tecnológico de Estudios Superiores de Monterrey, Monterrey, NL, Mexico
3Clínica Gómez-Almaguer, Monterrey, NL, Mexico

5:00 PM

Filippo Milano, MD1,2, Ann Dahlberg, MD1,2,3*, Laura C Roberts1*, Jenna B Pedersen1*, Sarah M Mahan1*, Katie E Kraskouskas, BA1*, Brandon E Hadland, MD, PhD1, Francesco Mazziotta, MD, PhD1 and Colleen Delaney, MD, MSc4,5*

1Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
4Deverra Therapeutics, Seattle, WA
5Children's Hospital, Seattle, WA

5:15 PM

Rongrong Liu1*, Hongwen Xiao, MD1*, Chunjie Qin2*, Jiong Hu, MD3, Jianming Luo4*, Hong Chen2*, Xi Zhang, PhD5, Xiaolin Yin6*, Guanye Nai7*, Guyun Wan8*, Zan Li9*, Wei Tang10*, Hua Zhang11*, Xiaotao Wang12*, Mei Lan, MD13*, Chuande Liao14*, Tonghua Yang15*, Sanbin Wang16*, Jinxiong Huang17*, Yunyan He4*, Li Wang18*, Zhongming Zhang1*, Lianjin Liu1*, Zhenbin Wei1*, Lingling Shi, MD1*, Meiqing Wu1*, Qi Zhou19*, Borje S. Andersson, MD, PhD20,21,22, Xiao Jun Huang23,24 and Yongrong Lai, MD1*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Department of Hematology, Liuzhou Worker’s Hospital, Liuzhou, China
3Shanghai Institute of Hematology, RuiJin Hospital Medical School, Shanghai JiaoT, Shanghai, China
4Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
5Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China
6Department of Hematology, 923rd Hospital of the People's Liberation Army, Nanning, China
7Department of Hematology ,The Affiliated Hospital of Youjiang Medical College, Baise, China
8Department of Hematology , Hainan Provincial People's Hospital, Haikou, China
9Department of Hematology, Maoming People's Hospital, Maoming, China
10Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
11Department of Hematology , Yulin Red Cross Hospital, Yulin, China
12Department of Hematology, The Affiliated Hospital of Guilin Medical College, Guilin, China
13The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
14Department of Pediatrics, Wuzhou People's Hospital, Wuzhou, China
15Department of Hematology , The First People's Hospital of Yunnan Province, Kunming,, China
16Department of hematology, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan, China
17Department of Hematology, Liuzhou People’s Hospital, Liuzhou, China
18Department of Pediatrics, 923rd Hospital of the People's Liberation Army, Nanning, China
19Gobroad Research Center, Shanghai, China
20M.D. Anderson Cancer Center, Houston, TX
21Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston
22Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
23Peking University People's Hospital, Beijing, China
24Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

*signifies non-member of ASH